Global Markets for Emerging Medical Device Technologies

Report Highlights

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Report Includes

• 70 data tables and 56 additional tables
• Analyses of the global market trends for emerging medical device technologies, with market revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue prospects, along with a corresponding market share analysis by disease indication, application, end user and region
• Discussion of the market potential and opportunities in the medical device industry, along with an analysis of the competitive environment, regulatory scenario, and technological advances
• Facts and figures pertaining to R&D activity, technology issues, industry-specific challenges, and the impact of macroeconomic factors
• A look at the regulatory and pricing scenarios in the global market, with an emphasis on recent regulations in the U.S., Europe and Japan
• Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
• Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Evaluation of recent patent activity and key granted and published patents
• Company profiles of major players within the industry, including Medtronic, Abbott, Siemens Healthineers AG, Boston Scientific Corp., and Johnson & Johnson Services Inc.

Report Scope

This report provides an in-depth analysis of the emerging medical device technology market, including market estimations and trends through 2029. Major players, competitive insights, imaginative innovations, advertising flow and geographic opportunities are examined in detail. The report looks at product innovations and item portfolios of major players. The report covers drivers, restraints, opportunities, emerging technologies and a regulatory scenario assessment. The report includes market projections for 2029 and market shares for key players.

The report's scope encompasses developing therapeutic devices, advances that create the most worldwide income. Dental devices with new innovations and a few imaging devices utilized in dentistry are covered under other devices.

Based on device type, the market is segmented into in vitro diagnostics (IVD), cardiovascular devices, neurology, orthopedics, diabetic care, endoscopy, urology and others. Based on the end-user type, the market is segmented into hospitals and clinics, home healthcare, ambulatory surgical centers and diagnostic laboratories.

The market is segmented by geographic region into North America, Europe, Asia-Pacific and the Rest of the World. Also included in the regional breakdown are detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and Gulf Cooperation Council (GCC) countries. Each country's market is estimated with segmental analysis. For market estimates, data is provided for 2023 as the base year, with estimates for 2024 and a forecast value for 2029.

Analyst Credentials

Partha Sarathi Das– Associate Consultant-Life Science Research
Partha Sarathi has an experience of nearly a decade in multiple domains, including healthcare, life science, biotechnology, pharmaceuticals, and healthcare IT. His expertise is in designing research studies, gathering data, and performing analysis, ultimately providing clients with actionable insights and recommendations based on their unique business needs. Designs proposal and participates in client queries for quick delivery based on their unique business needs. Academically, Parthasarathi holds a master’s degree in Biotechnology and a bachelor’s degree in Industrial Biotechnology.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.